Schmalz G, Berisha L, Wendorff H, Widmer F, Marcinkowski A, Teschler H, Sommerwerck U, Haak R, Kollmar O, Ziebolz D. Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation. Med Oral Patol Oral Cir Bucal. 2018 May 1;23 (3):e326-34.
doi:10.4317/medoral.22238
http://dx.doi.org/doi:10.4317/medoral.22238
1.
Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontol 2000. 2015;69:7-17. |
|
|
|
2.
Seymour RA. Effects of medications on the periodontal tissues in health and
disease. Periodontol.
2006;40:120-9. |
|
|
|
3.
Lipari WA, Blake LC, Zipkin I. Preferential response of the periodontal
apparatus and epiphyseal plate to hydrocortisone and fluoride in the rat. J Periodontol. 1974;45:879. |
|
|
|
4.
Helenius-Hietala J, Ruokonen H, Grönroos L, Rissanen H, Vehkalahti MM,
Suominen L, et al. Oral mucosal health in liver transplant
recipients and controls. Liver Transpl. 2014;20:72-80. |
|
|
|
5. Cota LO,
Aquino DR, Franco GC, Cortelli JR, Cortelli SC, Costa FO. Gingival
overgrowth in subjects under immunosuppressive regimens based on
cyclosporine, tacrolimus, or sirolimus. J Clin Periodontol. 2010;37:894-902. |
|
|
|
6. Schmalz
G, Kauffels A, Kollmar O, Slotta JE, Vasko R, Müller GA, et al. Oral behavior, dental, periodontal and microbiological findings in
patients undergoing hemodialysis and after kidney transplantation. BMC Oral
Health. 2016;16:72. |
|
|
|
7.
Marcinkowski A, Ziebolz D, Kleibrink BE, Weinreich G, Kamler M, Teschler H,
et al. Deficits in oral health behavior and oral health status in patients
after lung transplantation. Clin
Respir J. 2018;12:721-730. |
|
|
|
8.
Ziebolz D, Schmalz G, Kauffels A et al. Periodontal pathogenic bacteria and
aMMP-8 findings depending on periodontal conditions of patients before and
after liver transplantation. Clin
Oral Investig. 2017;21:745-752. |
|
|
|
9. Berezow AB, Darveau RP. Microbial shift and periodontitis. Periodontol. 2000;55:36-47. |
|
|
|
10. Mendes
L, Azevedo NF, Felino A, Pinto MG. Relationship between
invasion of the periodontium by periodontal pathogens and periodontal
disease: a systematic review. Virulence. 2015;6:208-215. |
|
|
|
11.
Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial
complexes in subgingival plaque. J Clin Periodontol. 1998;25:134-44. |
|
|
|
12. Leung
WK, Yau JY, Jin LJ et al. Subgingival microbiota of renal
transplant recipients. Oral Microbiol Immunol. 2003;18:37-44. |
|
|
|
13. Vieira
ML, Martins WJ, Grisi MF, Novaes AB, Souza SL, Salvador SL. Clinical
and microbiological analysis of periodontally diseased sites after renal
transplant. Spec Care Dentist. 2002;22:115-20. |
|
|
|
14.
Saraiva L, Lotufo RF, Pustiglioni AN, Silva HT Jr, Imbronito AV. Evaluation
of subgingival bacterial plaque changes and effects on periodontal tissues in
patients with renal transplants under immunosuppressive therapy. Oral Surg
Oral Med Oral Pathol Oral Radiol Endod. 2006;101:457-62. |
|
|
|
15.
Kauffels A, Schmalz G, Kollmar O, Slotta JE, Weig M, Groß U, et al. Oral
findings and dental behavior before and after liver transplantation – a
single center cross-sectional study. Int Dent J. 2017;67:244-251. |
|
|
|
16.
Lange DE, Plagmann HC, Eenboom A, Promesberger A. Clinical methods for the
objective evaluation of oral hygiene. Dtsch Zahnarztl Z. 1977;32:44-7. |
|
|
|
17.
Page RC, Eke PI. Case Definitions for Use in Population-Based Surveillance of
Periodontitis. J
Periodontol. 2007;78:1387-99. |
|
|
|
18.
Alani A, Seymour R. Systemic medication and the inflammatory cascade. Periodontol 2000. 2014;64:198–210. |
|
|
|
19.
Been V, Engel D. The effects of immunosuppressive drugs on periodontal
inflammation in human renal allograft patients. J Periodontol. 1982;53:245-8. |
|
|
|
20.
Kardachi BJ, Newcomb GM. A clinical study of gingival inflammation in renal
transplant recipients taking immunosuppressive drugs. J Periodontol. 1978:49:307–9. |
|
|
|
21.
Trackman PC, Kantarci A. Connective tissue metabolism and gingival
overgrowth. Crit Rev Oral
Biol Med. 2004;15:165-75. |
|
|
|
22. da Silva
Peralta F, Pallos D, Silva Queiroz C, Ricardo LH. Previous
exposure to Cyclosporine A and periodontal breakdown in rats. Arch
Oral Biol. 2015;60:566-73. |
|
|
|
23. Nassar
PO, Felipetti FA, Nassar CA, Spolidorio LC. Evaluation of
effect of cyclosporine A on the bone tissue with induced periodontal disease
to ligature in rats. Transplant Proc. 2013;45:778-82. |
|
|
|
24. Abusleme
L, Dupuy AK, Dutzan N et al. The subgingival microbiome in
health and periodontitis and its relationship with community biomass and
inflammation. ISME J. 2013;7:1016-25. |
|
|
|
25.
Marsh PD, Moter A, Devine DA. Dental plaque biofilms: communities, conflict
and control. Periodontol
2000. 2011;55:16-35. |
|
|
|
26.
Loesche WJ. Bacterial mediators in periodontal disease. Clin Infect Dis.
1993;16:S203-210. |
|
|
|
27.
Lamont RJ, Chan A, Belton CM, Izutsu KT, Vasel D, Weinberg A. Porphyromonas
gingivalis invasion of gingival epithelial cells. Infect Immun. 1995;63:3878–85. |
|
|
|
28.
Kolenbrander PE, Andersen RN. Moore LVH. Coaggregation of Fusobacterium
nucleatum, Selenomonas flueggei, Selenomonas infelix, Selenomonas noxia, and
Selenomonas sputigena with strains from 11 genera of oral bacteria. Infect Immun. 1989;57:3194-203. |
|
|
|
29.
Bradshaw DJ, Marsh PD. Analysis of pH-driven disruption of oral microbial
communities in vitro. Caries
Res. 1998;32:456–62. |
|
|
|
30.
Untch M, Schlagenhauf U. Inter- and intra-test agreement of three
commercially available molecular diagnostic tests for the identification of
periodontal pathogens. Clin
Oral Invest. 2015;19:2045–52. |